Primary Chondrosarcoma in L-shaped Crossed Fused Renal Ectopia Coexisting with Papillary Urothelial Carcinoma in Urinary Bladder – An Enigmatic Entity with Poor Prognosis

Main Article Content

Mayank Kumar
Aasma Nalwa
Taruna Yadav
Poonam Elhence
Himanshu Pandey
Meenakshi Rao

Keywords

chondrosarcoma, kidney, renal ectopia, urinary bladder, urothelial carcinoma

Abstract

Primary renal chondrosarcomas are rare tumors that are high-grade in nature and, unfortunately, have poorly understood pathogenesis and extremely low prognosis. The coexistence of a discrete malignancy in the urinary bladder is even rarer, with the occurrence of distinct papillary urothelial carcinoma in the urinary bladder in this case. The clinical presentation is nonspecific, and the primary radiological investigations have a limited scope in providing specific diagnosis of this entity. The final diagnosis is possible on thorough histopathological examination of the resected specimen, which requires extensive sampling and meticulous reporting. As of now, the only way to achieve a better prognosis is by early diagnosis. It is necessary to keep the possibility of occurrence of sarcomas at rare sites in the differential diagnoses. The cytogenetic and molecular abnormalities associated with this entity need to be elucidated to achieve a more satisfactory outcome concerning the overall management of the patient.

Abstract 1119 | PDF Downloads 1116 HTML Downloads 264 XML Downloads 222

References

1. Buse S, Behnisch W, Kulozik A, Autschbach F, Hohenfellner M. Primary Chondrosarcoma of the Kidney: Case Report and Review of the Literature. Urol Int. 2009;83:116–8. 10.1159/000224880

2. Chen D, Ye ZI, Wu X, Shi B, Zhou L, Sun S, Wei B, et al. Primary mesenchymal chondrosarcoma with bilateral kidney invasion and calcification in renal pelvis: A case report and review of the literature. Oncol Lett. 2015;10:1075–8. 10.3892/ol.2015.3252

3. Xu H, Shao M, Sun H, Li S. Primary mesenchymal chondrosarcoma of the kidney with synchronous implant and infiltrating urothelial carcinoma of the ureter. Diagn Pathol. 2012;7:125–7. 10.1186/1746-1596-7-125

4. Takuji K, Suzuki Y, Takata RYO, Takata KOH, Sakuma T, Fujioka T. Extraskeletal mesenchymal chondrosarcoma of the kidney. Int J Urol. 2006; 13:285–6. 10.1111/j.1442-2042.2006.01293.x

5. Malhotra C, Doolittle C, Rodil J, Vezeridis M. Mesenchymal chondrosarcoma of the kidney. Cancer. 1984;54:2495–9. 10.1002/1097-0142(19841201)54:11<2495::AID-CNCR2820541130>3.0.CO;2-G

6. Daniel R, Silvia G, De la Cueva T, Paz M, Lloyd A, Antonio B, et al. Human mesenchymal stem cell transformation is associated with a mesenchymal-epithelial transition. Exp Cell Res. 2008;314:691–8. 10.1016/j.yexcr.2007.11.017

7. Tyagi R, Kakkar N, Vasishta RK, Aggarwal MM. Mesenchymal chondrosarcoma of kidney. Int J Urol. 2014;30:225–7. 10.4103/0970-1591.126914

8. Husain A, Eigl B, Trpkov K. Composite chromophobe renal cell carcinoma with sarcomatoid differentiation containing osteosarcoma, chondrosarcoma, squamous metaplasia and associated collecting duct carcinoma: A case report. Anal Quant Cytopathol Histopathol. 2014;36:235–40. Available from: https://pubmed.ncbi.nlm.nih.gov/25291862/

9. Callagher J, Winslow D, Grossman A. Coexistent chondrosarcoma and transitional-cell carcinoma in kidney. Urology. 1974;3:473–7. 10.1016/S0090-4295(74)80167-6

10. Mehanna D, Rao S. Liver metastasis in renal chondrosarcoma. Singapore Med J. 2004;45:183–5. Available from: https://pubmed.ncbi.nlm.nih.gov/15094989/

11. Pani KC, Yadav M, Priyaa PV, Kumari N. Extraskeletal mesenchymal chondrosarcoma at unusual location involving spleen and kidney with review of literature. Ind J Pathol Microbiol. 2017;60:262–5. 10.4103/IJPM.IJPM_16_16

12. Lee A, Hayes M, Lebrun D, Espinosa I, Nielsen G, Rosenberg A, et al. FLI-1 distinguishes Ewing sarcoma from small cell osteosarcoma and mesenchymal chondrosarcoma. Appl Immunohistochem Mol Morphol. 2011;19:233–8. 10.1097/PAI.0b013e3181fd6697

13. Wang L, Motoi T, Khanin R, Olshen A, Mertens F, Bridge J, et al. Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes Chromosomes Cancer. 2012;51:127–39. 10.1002/gcc.20937

14. Terek RM, Healey JH, Garin-Chesa P, Mak S, Huvos A, Albino AP. p53 mutations in chondrosarcoma. Diagn Mol Pathol. 1998;7:51–6. 10.1097/00019606-199802000-00009

15. Noon AP, Vlatkovic N, Polanski R, Maguire M, Shawki H, Parsons K, et al. p53 and MDM2 in renal cell carcinoma: Biomarkers for disease progression and future therapeutic targets? Cancer. 2010;116:780–90. 10.1002/cncr.24841

16. Gherman V, Tomuleasa C, Bungardean C, Crisan N, Ona V, Feciche B, et al. Management of renal extraskeletal mesenchymal chondrosarcoma. BMC Surg. 2014;14:107–10. 10.1186/1471-2482-14-107

17. Salehipour M, Hosseinzadeh M, Sisakhti AM, Parvin VAM, Sadraei A, Adib A. Renal extra skeletal mesenchymal chondrosarcoma: A case report. Urol Case Rep. 2017;12:23–5. 10.1016/j.eucr.2016.12.013